Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Corrigendum to “Synthesis of 3′-C-branched 1′,5′-anhydromannitol nucleosides as new antiherpes agents” [Tetrahedron 54 (1998) 2209] — Nafizal Hossain (1998) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Corrigendum to “Synthesis of 3′-C-branched 1′,5′-anhydromannitol nucleosides as new antiherpes agents” [Tetrahedron 54 (1998) 2209]
Shared by
De Clercq Erik
KU Leuven
Corrigendum to “Synthesis of 3′-C-branched 1′,5′-anhydromannitol nucleosides as new antiherpes agents” [Tetrahedron 54 (1998) 2209]
Corrigendum
1998
en
Authors
+1 more
NH
Nafizal Hossain
HH
Herman van Halbeek
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
Synthesis of 3′-C-branched 1′,5′-anhydromannitol nucleosides as new antiherpes agents
Nafizal Hossain
,
Herman van Halbeek
,
De Clercq Erik
,
Piet Herdewijn
Article
1981
Pyrimidine arabinofuranosyl nucleosides with 5-substituted long, branched and unsaturated chains: synthesis and antiherpes properties.
Tadeusz Kulikowski
,
Z Zawadzki
,
David Shugar
,
De Clercq Erik
Article
1979
Synthesis and antiviral activities of arabinofuranosyl-5-ethylpyrimidine nucleosides. Selective antiherpes activity of 1-(.beta.-D-arabinofuranosyl)-5-ethyluracil
Tadeusz Kulikowski
,
Z Zawadzki
,
David Shugar
,
J Descamps
,
De Clercq Erik
Article
1979
ChemInform Abstract: SYNTHESIS AND ANTIVIRAL ACTIVITIES OF ARABINOFURANOSYL‐5‐ETHYLPYRIMIDINE NUCLEOSIDES. SELECTIVE ANTIHERPES ACTIVITY OF 1‐(β‐D‐ARABINOFURANOSYL)‐5‐ETHYLURACIL
Tadeusz Kulikowski
,
Z Zawadzki
,
David Shugar
,
J Descamps
,
De Clercq Erik
Article
2008
ChemInform Abstract: Microwave‐Assisted Synthesis and anti‐HIV Activity of New Acyclic C‐Nucleosides of 3‐(D‐ribo‐Tetritol‐1‐yl)‐5‐mercapto‐1,2,4‐triazoles. Part 1.
Yaseen A. Al‐Soud
,
Najim A. Al‐Masoudi
,
Thilo Schuppler
,
De Clercq Erik
,
Christophe Pannecouque
Discussion(0)
No comments yet. Be the first to comment.